Report

1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.3 STUDY SCOPE 43
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 43
1.3.2 INCLUSIONS AND EXCLUSIONS 44
1.3.3 YEARS CONSIDERED 44
1.4 CURRENCY CONSIDERED 45
1.5 STAKEHOLDERS 45
1.6 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
2.1.1 SECONDARY DATA 48
2.1.2 PRIMARY DATA 49
2.2 MARKET SIZE ESTIMATION 50
2.2.1 GLOBAL MARKET SIZE ESTIMATION 50
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 53
2.2.3 SEGMENTAL MARKET ASSESSMENT 53
2.3 GROWTH FORECAST MODEL 55
2.4 DATA TRIANGULATION 57
2.5 RESEARCH ASSUMPTIONS 58
2.6 RESEARCH LIMITATIONS 59
2.7 RISK ANALYSIS 59
3 EXECUTIVE SUMMARY 60
4 PREMIUM INSIGHTS 65
4.1 EPIGENETICS MARKET OVERVIEW 65
4.2 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY 66
4.3 EPIGENETICS PRODUCT MARKET, BY END USER, 2024 66
4.4 EPIGENETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
5.2.1 DRIVERS 69
5.2.1.1 Declining sequencing costs and time 69
5.2.1.2 Growing emphasis on population-scale screening initiatives 71
5.2.1.3 Technological advancements in epigenetics research 71
5.2.1.4 Rising demand for epigenetic drugs and epigenetic-based therapeutics 72
5.2.2 RESTRAINTS 73
5.2.2.1 Limited applications of epigenomic data in toxicology 73
5.2.2.2 Data privacy concerns and security issues 74
5.2.3 OPPORTUNITIES 74
5.2.3.1 Emerging applications of epigenetics 74
5.2.3.2 Integration of multi-omics 75
5.2.4 CHALLENGES 75
5.2.4.1 Concerns regarding quality of antibodies 75
5.2.4.2 Challenges associated with epigenetic editing 76
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76
5.4 PRICING ANALYSIS 77
5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 77
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 80
5.5 VALUE CHAIN ANALYSIS 82
5.6 ECOSYSTEM ANALYSIS 84
5.7 INVESTMENT AND FUNDING SCENARIO 87
5.8 TECHNOLOGY ANALYSIS 89
5.8.1 KEY TECHNOLOGIES 89
5.8.1.1 Single-cell sequencing 89
5.8.1.2 Chromatin immunoprecipitation 89
5.8.2 COMPLEMENTARY TECHNOLOGIES 89
5.8.2.1 DNA methylation microarrays 89
5.8.2.2 CRISPR-based genome editing 89
5.9 PATENT ANALYSIS 90
5.10 TRADE DATA ANALYSIS 92
5.10.1 IMPORT DATA 93
5.10.2 EXPORT DATA 94
5.11 KEY CONFERENCES AND EVENTS, 2025-2026 96
5.12 TARIFF AND REGULATORY LANDSCAPE 97
5.12.1 TARIFF DATA FOR HS CODES 9027.50.80 AND 3822.00 97
5.12.2 REGULATORY FRAMEWORK 98
5.12.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
5.13 PORTER'S FIVE FORCES ANALYSIS 103
5.13.1 BARGAINING POWER OF SUPPLIERS 104
5.13.2 BARGAINING POWER OF BUYERS 104
5.13.3 THREAT OF NEW ENTRANTS 105
5.13.4 THREAT OF SUBSTITUTES 105
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 105
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 105
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 106
5.14.2 KEY BUYING CRITERIA 107
5.15 IMPACT OF AI/GEN AI ON EPIGENETICS MARKET 108
5.15.1 INTRODUCTION 108
5.15.2 MARKET POTENTIAL OF AI IN EPIGENETICS 108
5.15.3 AI USE CASES 108
5.15.4 KEY COMPANIES IMPLEMENTING AI/GEN AI 109
5.15.5 FUTURE OF AI/GEN AI IN EPIGENETICS MARKET 109
5.16 IMPACT OF 2025 US TARIFF 110
5.16.1 INTRODUCTION 110
5.16.2 KEY TARIFF RATES 110
5.16.3 PRICE IMPACT ANALYSIS 113
5.16.4 KEY IMPACTS ON VARIOUS REGIONS 114
5.16.4.1 US 114
5.16.4.2 Europe 114
5.16.4.3 Asia Pacific 114
5.16.5 END-USE INDUSTRY IMPACT 115
5.16.5.1 Pharmaceutical and biotech companies 115
5.16.5.2 Contract Research Organizations (CROs) 115
5.16.5.3 Academic and research institutes 115
6 EPIGENETICS MARKET, BY OFFERING 116
6.1 INTRODUCTION 117
6.2 KITS & REAGENTS 118
6.2.1 ANTIBODIES 122
6.2.1.1 Growing demand for recombinant antibodies for detection of epigenetic targets to propel market 122
6.2.2 CHIP-SEQUENCING KITS & REAGENTS 125
6.2.2.1 Versatile applications of chromatin immunoprecipitation pertaining to epigenetic regulatory systems to boost market 125
6.2.3 BISULFITE CONVERSION KITS & REAGENTS 129
6.2.3.1 Effective outcomes associated with bisulfite conversion to sustain growth 129
6.2.4 WHOLE-GENOME AMPLIFICATION KITS & REAGENTS 132
6.2.4.1 Ability to maintain relative proportions of genes in original pool to stimulate growth 132
6.2.5 5-HMC & 5-MC ANALYSIS KITS & REAGENTS 136
6.2.5.1 Introduction of unique kits for 5-mC and 5-hmC analysis to support growth 136
6.2.6 HISTONES 139
6.2.6.1 Emerging importance of chromatin-associated proteins and histones in epigenetic research to bolster growth 139
6.2.7 OTHER KITS & REAGENTS 143
6.3 ENZYMES 147
6.3.1 DNA-MODIFYING ENZYMES 150
6.3.1.1 Broadening applications of DNA methylation to facilitate growth 150
6.3.2 PROTEIN-MODIFYING ENZYMES 154
6.3.2.1 Increasing pipeline of epigenetics-based drugs targeting histone-modifying enzymes to spur growth 154
6.3.3 OTHER ENZYMES 157
6.4 INSTRUMENTS & ACCESSORIES 160
6.4.1 WIDE USAGE OF NGS INSTRUMENTS AND SONICATORS TO EXPEDITE GROWTH 160
6.5 SOFTWARE 164
6.5.1 DEVELOPMENT OF VIABLE SOFTWARE SOLUTIONS FOR DNA METHYLATION AND RNA ANALYSIS TO PROMOTE GROWTH 164
6.6 SERVICES 167
6.6.1 EXPANDING POOL OF SERVICE PROVIDERS TO DRIVE MARKET 167
7 EPIGENETICS MARKET, BY TECHNOLOGY 171
7.1 INTRODUCTION 172
7.2 NEXT-GENERATION SEQUENCING (NGS) 172
7.2.1 INCREASING LAUNCHES OF NEXT-GENERATION SEQUENCING PLATFORMS TO FACILITATE GROWTH 172
7.3 PCR & QPCR 177
7.3.1 RISING NUMBER OF PCR-BASED EPIGENETICS SERVICE PROVIDERS TO DRIVE MARKET 177
7.4 MASS SPECTROMETRY 181
7.4.1 GROWING DEMAND FOR MASS SPECTROMETRY IN COMPREHENSIVE STUDIES ON HISTONE EPIGENETICS TO BOOST MARKET 181
7.5 SONICATION 185
7.5.1 RISING USE OF SONICATION IN SCIENTIFIC AND INDUSTRIAL SETTINGS TO EXPEDITE GROWTH 185
7.6 OTHER TECHNOLOGIES 188
8 EPIGENETICS MARKET, BY METHOD 192
8.1 INTRODUCTION 193
8.2 DNA METHYLATION 193
8.2.1 INCREASING RESEARCH & DEVELOPMENT ACTIVITIES TO SPUR GROWTH 193
8.3 HISTONE MODIFICATIONS 197
8.3.1 GROWING TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 197
8.4 OTHER METHODS 201
?
9 EPIGENETICS MARKET, BY APPLICATION 204
9.1 INTRODUCTION 205
9.2 ONCOLOGY 205
9.2.1 GROWING INVESTMENT IN EPIGENETIC-BASED RESEARCH TO BOOST MARKET 205
9.3 METABOLIC DISEASES 211
9.3.1 EMERGING ROLE OF DNA METHYLATION IN DIABETES MANAGEMENT TO FAVOR GROWTH 211
9.4 IMMUNOLOGY 214
9.4.1 GROWING DEMAND FOR EPIGENETIC PRODUCTS IN TUMOR AND TRANSPLANTATION IMMUNOLOGY TO DRIVE MARKET 214
9.5 DEVELOPMENTAL BIOLOGY 218
9.5.1 INCREASING RESEARCH ON CELL GROWTH AND DIFFERENTIATION TO PROPEL MARKET 218
9.6 CARDIOVASCULAR DISEASES 221
9.6.1 EMERGING ROLE OF EPIGENETICS IN UNDERSTANDING ETIOLOGY OF CARDIOVASCULAR DISEASES TO AID GROWTH 221
9.7 OTHER APPLICATIONS 225
10 EPIGENETICS PRODUCTS MARKET, BY END USER 229
10.1 INTRODUCTION 230
10.2 ACADEMIC & RESEARCH INSTITUTES 230
10.2.1 INCREASING PUBLIC-PRIVATE COLLABORATIONS TO FAVOR GROWTH 230
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 234
10.3.1 GROWING NUMBER OF CLINICAL TRIALS FOR EPIGENETIC-BASED DRUGS TO FUEL MARKET 234
10.4 HOSPITALS & CLINICS 238
10.4.1 GROWING USE OF PERSONALIZED MEDICINE TO PROPEL MARKET 238
10.5 CONTRACT RESEARCH ORGANIZATIONS 242
10.5.1 INCREASING DEMAND FOR SCALABLE, HIGH-THROUGHPUT EPIGENETICS KITS TO PROMOTE GROWTH 242
11 EPIGENETICS SERVICE MARKET, BY END USER 246
11.1 INTRODUCTION 247
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 247
11.2.1 RISING DEMAND FOR THERAPEUTIC DISCOVERIES TO BOLSTER GROWTH 247
11.3 ACADEMIC & RESEARCH INSTITUTES 251
11.3.1 INCREASING VOLUME OF HIGH-THROUGHPUT EPIGENOMIC DATA TO AUGMENT GROWTH 251
11.4 HOSPITALS & CLINICS 254
11.4.1 INCREASING INTEGRATION OF EPIGENETIC ASSAYS INTO CLINICAL DIAGNOSTICS, PROGNOSTICS, AND PERSONALIZED MEDICINE TO AID GROWTH 254
?
12 EPIGENETICS MARKET, BY REGION 258
12.1 INTRODUCTION 259
12.2 NORTH AMERICA 259
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 259
12.2.2 US 266
12.2.2.1 Strong network of well-established epigenetic product manufacturers to spur growth 266
12.2.3 CANADA 270
12.2.3.1 Favorable government initiatives to contribute to growth 270
12.3 EUROPE 275
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 275
12.3.2 GERMANY 281
12.3.2.1 Significant investments in next-generation sequencing to bolster growth 281
12.3.3 UK 285
12.3.3.1 Rising acceptance of genome-based diagnostic techniques to support growth 285
12.3.4 FRANCE 290
12.3.4.1 Growing demand for PCR technologies to drive market 290
12.3.5 ITALY 295
12.3.5.1 High incidence of cancer to expedite growth 295
12.3.6 SPAIN 300
12.3.6.1 Well-established network of research centers and universities to boost market 300
12.3.7 REST OF EUROPE 304
12.4 ASIA PACIFIC 308
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 308
12.4.2 CHINA 315
12.4.2.1 High demand for personalized medicine to accelerate growth 315
12.4.3 JAPAN 320
12.4.3.1 Increasing collaborations between research & academic organizations to favor growth 320
12.4.4 INDIA 325
12.4.4.1 Expanding base of biotechnology facilities to drive market 325
12.4.5 AUSTRALIA 330
12.4.5.1 Growing hub for epigenetics to propel market 330
12.4.6 SOUTH KOREA 334
12.4.6.1 Rising burden of chronic diseases to foster growth 334
12.4.7 REST OF ASIA PACIFIC 338
?
12.5 LATIN AMERICA 342
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 342
12.5.2 BRAZIL 347
12.5.2.1 Increasing number of healthcare providers incorporating epigenetic testing to aid growth 347
12.5.3 MEXICO 351
12.5.3.1 Growing adoption of cutting-edge technologies to drive market 351
12.5.4 REST OF LATIN AMERICA 355
12.6 MIDDLE EAST 359
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 359
12.6.2 GCC COUNTRIES 365
12.6.2.1 Saudi Arabia 370
12.6.2.1.1 Growing healthcare expenditure to propel market 370
12.6.2.2 UAE 375
12.6.2.2.1 Increasing collaborations between public and private sectors to spur growth 375
12.6.2.3 Rest of GCC countries 379
12.6.3 REST OF MIDDLE EAST 383
12.7 AFRICA 387
12.7.1 RISING DEMAND FOR TARGETED THERAPIES TO AUGMENT GROWTH 387
12.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 387
13 COMPETITIVE LANDSCAPE 393
13.1 INTRODUCTION 393
13.2 KEY PLAYER STRATEGIES 393
13.3 REVENUE ANALYSIS 395
13.4 MARKET SHARE ANALYSIS 395
13.5 COMPANY VALUATION AND FINANCIAL METRICS 398
13.6 BRAND/PRODUCT COMPARISON 399
13.6.1 THERMO FISHER SCIENTIFIC INC. 399
13.6.2 ILLUMINA, INC. 399
13.6.3 MERCK KGAA 400
13.6.4 DANAHER 400
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 400
13.7.1 STARS 400
13.7.2 EMERGING LEADERS 400
13.7.3 PERVASIVE PLAYERS 400
13.7.4 PARTICIPANTS 401
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 402
13.7.5.1 Company footprint 402
13.7.5.2 Region footprint 403
13.7.5.3 Offering footprint 403
13.7.5.4 Method footprint 404
13.7.5.5 Technology footprint 405
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 406
13.8.1 PROGRESSIVE COMPANIES 406
13.8.2 RESPONSIVE COMPANIES 406
13.8.3 DYNAMIC COMPANIES 406
13.8.4 STARTING BLOCKS 406
13.8.5 COMPETITIVE BENCHMARKING 408
13.8.5.1 Detailed list of key startups/SMEs 408
13.8.5.2 Competitive benchmarking of key startups/SMEs 409
13.9 COMPETITIVE SCENARIO 409
13.9.1 PRODUCT LAUNCHES 409
13.9.2 DEALS 411
13.9.3 EXPANSIONS 412
14 COMPANY PROFILES 413
14.1 KEY MARKET PLAYERS 413
14.1.1 THERMO FISHER SCIENTIFIC INC. 413
14.1.1.1 Business overview 413
14.1.1.2 Products offered 414
14.1.1.3 Recent developments 416
14.1.1.3.1 Product launches 416
14.1.1.3.2 Deals 417
14.1.1.4 MnM view 417
14.1.1.4.1 Key strengths 417
14.1.1.4.2 Strategic choices 417
14.1.1.4.3 Weaknesses and competitive threats 417
14.1.2 ILLUMINA, INC. 418
14.1.2.1 Business overview 418
14.1.2.2 Products offered 419
14.1.2.3 Recent developments 421
14.1.2.3.1 Product launches 421
14.1.2.3.2 Deals 421
14.1.2.4 MnM view 422
14.1.2.4.1 Key strengths 422
14.1.2.4.2 Strategic choices 422
14.1.2.4.3 Weaknesses and competitive threats 422
14.1.3 MERCK KGAA 423
14.1.3.1 Business overview 423
14.1.3.2 Products offered 424
14.1.3.3 MnM view 426
14.1.3.3.1 Key strengths 426
14.1.3.3.2 Strategic choices 426
14.1.3.3.3 Weaknesses and competitive threats 426
14.1.4 PACBIO 427
14.1.4.1 Business overview 427
14.1.4.2 Products offered 428
14.1.4.3 Recent developments 429
14.1.4.3.1 Product launches 429
14.1.4.3.2 Deals 430
14.1.4.3.3 Expansions 430
14.1.4.4 MnM view 431
14.1.4.4.1 Key strengths 431
14.1.4.4.2 Strategic choices 431
14.1.4.4.3 Weaknesses and competitive threats 431
14.1.5 DANAHER 432
14.1.5.1 Business overview 432
14.1.5.2 Products offered 433
14.1.5.3 Recent developments 435
14.1.5.3.1 Deals 435
14.1.5.4 MnM view 435
14.1.5.4.1 Key strengths 435
14.1.5.4.2 Strategic choices 435
14.1.5.4.3 Weaknesses and competitive threats 435
14.1.6 BIO-RAD LABORATORIES, INC. 436
14.1.6.1 Business overview 436
14.1.6.2 Products offered 437
14.1.7 ACTIVE MOTIF 441
14.1.7.1 Business overview 441
14.1.7.2 Products offered 441
14.1.7.3 Recent developments 444
14.1.7.3.1 Deals 444
14.1.8 NEW ENGLAND BIOLABS 445
14.1.8.1 Business overview 445
14.1.8.2 Products offered 445
14.1.8.3 Recent developments 447
14.1.8.3.1 Product launches 447
14.1.8.3.2 Deals 448
14.1.9 QIAGEN 449
14.1.9.1 Business overview 449
14.1.9.2 Products offered 450
14.1.9.3 Recent developments 451
14.1.9.3.1 Product launches 451
?
14.1.10 ZYMO RESEARCH CORPORATION 452
14.1.10.1 Business overview 452
14.1.10.2 Products offered 452
14.1.10.3 Recent developments 455
14.1.10.3.1 Product launches 455
14.1.10.3.2 Expansions 455
14.1.10.3.3 Other developments 455
14.1.11 REVVITY 456
14.1.11.1 Business overview 456
14.1.11.2 Products offered 457
14.1.11.3 Recent developments 458
14.1.11.3.1 Deals 458
14.1.12 HOLOGIC, INC. 459
14.1.12.1 Business overview 459
14.1.12.2 Products offered 460
14.1.13 F. HOFFMANN-LA ROCHE LTD 463
14.1.13.1 Business overview 463
14.1.13.2 Products offered 464
14.1.14 PROMEGA CORPORATION 466
14.1.14.1 Business overview 466
14.1.14.2 Products offered 466
14.1.15 EPIGENTEK GROUP INC. 468
14.1.15.1 Business overview 468
14.1.15.2 Products offered 468
14.2 OTHER PLAYERS 472
14.2.1 EPICYPHER 472
14.2.2 FIOS GENOMICS 473
14.2.3 GENOMESCAN 474
14.2.4 CREATIVE BIOGENE 475
14.2.5 BPS BIOSCIENCE, INC. 475
14.2.6 ABNOVA CORPORATION 477
14.2.7 CREATIVE DIAGNOSTICS 478
14.2.8 BIOMODAL 479
14.2.9 INTEGRATED DNA TECHNOLOGIES, INC. 480
14.2.10 NOVOGENE CO., LTD. 481
?
15 APPENDIX 482
15.1 DISCUSSION GUIDE 482
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 487
15.3 CUSTOMIZATION OPTIONS 489
15.4 RELATED REPORTS 489
15.5 AUTHOR DETAILS 490

TABLE 1 EPIGENETICS MARKET: INCLUSIONS AND EXCLUSIONS 44
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 56
TABLE 3 EPIGENETICS MARKET: RISK ANALYSIS 59
TABLE 4 EPIGENETICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 69
TABLE 5 AVERAGE SELLING PRICE TREND OF EPIGENETIC PRODUCTS, BY KEY PLAYER, 2022-2024 (USD MILLION) 77
TABLE 6 AVERAGE SELLING PRICE TREND OF EPIGENETIC INSTRUMENTS, BY REGION, 2022-2024 (USD MILLION) 80
TABLE 7 AVERAGE SELLING PRICE TREND OF EPIGENETIC KITS AND REAGENTS,
BY REGION, 2022-2024 (USD MILLION) 80
TABLE 8 AVERAGE SELLING PRICE TREND OF EPIGENETIC ENZYMES, BY REGION,
2022-2024 (USD MILLION) 80
TABLE 9 EPIGENETICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 86
TABLE 10 EPIGENETICS MARKET: INVESTMENT AND FUNDING SCENARIO OF KEY PLAYERS, 2022?2025 87
TABLE 11 EPIGENETICS MARKET: PATENTS FILED GLOBALLY, 2014?2024 90
TABLE 12 EPIGENETICS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2024-2025 92
TABLE 13 IMPORT VALUE OF HS CODE 9027.50- COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND) 93
TABLE 14 IMPORT VALUE OF HS CODE 382.00- COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND) 93
TABLE 15 EXPORT VALUE OF HS CODE 9027.50 - COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND) 94
TABLE 16 EXPORT VALUE OF HS CODE 3822.00 - COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020-2024 (USD THOUSAND) 95
TABLE 17 EPIGENETICS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026 96
TABLE 18 TARIFF DATA FOR HS CODES 9027.50.80 AND 3822.00 97
TABLE 19 KEY REGULATORY AGENCIES 98
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 24 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 25 AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 26 EPIGENETICS MARKET: PORTER'S FIVE FORCES ANALYSIS 103
TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 106
TABLE 28 KEY BUYING CRITERIA, BY END USER 107
TABLE 29 LIST OF COMPANIES IMPLEMENTING AI/GEN AI IN EPIGENETICS MARKET 109
TABLE 30 US ADJUSTED RECIPROCAL TARIFF RATES 110
TABLE 31 EXPORTS AND IMPORTS, BY REGION, 2024-2025 111
TABLE 32 KEY PRODUCT-RELATED TARIFF: HS CODES FOR PRODUCTS RELEVANT TO EPIGENETICS 112
TABLE 33 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 113
TABLE 34 EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 117
TABLE 35 EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 118
TABLE 36 EPIGENETICS MARKET FOR KITS & REAGENTS, BY REGION,
2023-2030 (USD MILLION) 119
TABLE 37 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 119
TABLE 38 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY,
2023-2030 (USD MILLION) 120
TABLE 39 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY,
2023-2030 (USD MILLION) 120
TABLE 40 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 121
TABLE 41 MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY REGION,
2023-2030 (USD MILLION) 121
TABLE 42 GCC COUNTRIES: EPIGENETICS MARKET FOR KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 121
TABLE 43 EPIGENETICS MARKET FOR ANTIBODIES, BY REGION, 2023-2030 (USD MILLION) 122
TABLE 44 NORTH AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY,
2023-2030 (USD MILLION) 123
TABLE 45 EUROPE: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY,
2023-2030 (USD MILLION) 123
TABLE 46 ASIA PACIFIC: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY,
2023-2030 (USD MILLION) 124
TABLE 47 LATIN AMERICA: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY,
2023-2030 (USD MILLION) 124
TABLE 48 MIDDLE EAST: EPIGENETICS MARKET FOR ANTIBODIES, BY REGION,
2023-2030 (USD MILLION) 124
TABLE 49 GCC COUNTRIES: EPIGENETICS MARKET FOR ANTIBODIES, BY COUNTRY,
2023-2030 (USD MILLION) 125
TABLE 50 EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 126
TABLE 51 NORTH AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 126
TABLE 52 EUROPE: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 127
TABLE 53 ASIA PACIFIC: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 127
TABLE 54 LATIN AMERICA: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 55 MIDDLE EAST: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 128
TABLE 56 GCC COUNTRIES: EPIGENETICS MARKET FOR CHIP-SEQUENCING KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 128
TABLE 57 EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS,
BY REGION, 2023-2030 (USD MILLION) 129
TABLE 58 NORTH AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 130
TABLE 59 EUROPE: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 130
TABLE 60 ASIA PACIFIC: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 61 LATIN AMERICA: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 131
TABLE 62 MIDDLE EAST: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 131
TABLE 63 GCC COUNTRIES: EPIGENETICS MARKET FOR BISULFITE CONVERSION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 132
TABLE 64 EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 133
TABLE 65 NORTH AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 133
TABLE 66 EUROPE: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 67 ASIA PACIFIC: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 134
TABLE 68 LATIN AMERICA: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 69 MIDDLE EAST: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 135
TABLE 70 GCC COUNTRIES: EPIGENETICS MARKET FOR WHOLE-GENOME AMPLIFICATION KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 135
TABLE 71 EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS,
BY REGION, 2023-2030 (USD MILLION) 136
TABLE 72 NORTH AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 73 EUROPE: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 137
TABLE 74 ASIA PACIFIC: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 75 LATIN AMERICA: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 138
TABLE 76 MIDDLE EAST: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 138
TABLE 77 GCC COUNTRIES: EPIGENETICS MARKET FOR 5-HMC & 5-MC ANALYSIS KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 139
TABLE 78 EPIGENETICS MARKET FOR HISTONES, BY REGION, 2023-2030 (USD MILLION) 140
TABLE 79 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY,
2023-2030 (USD MILLION) 140
TABLE 80 EUROPE: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY,
2023-2030 (USD MILLION) 141
TABLE 81 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY,
2023-2030 (USD MILLION) 141
TABLE 82 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY,
2023-2030 (USD MILLION) 142
TABLE 83 MIDDLE EAST: EPIGENETICS MARKET FOR HISTONES, BY REGION,
2023-2030 (USD MILLION) 142
TABLE 84 GCC COUNTRIES: EPIGENETICS MARKET FOR HISTONES, BY COUNTRY,
2023-2030 (USD MILLION) 142
TABLE 85 EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY REGION,
2023-2030 (USD MILLION) 144
TABLE 86 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 144
TABLE 87 EUROPE: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 145
TABLE 88 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION) 145
TABLE 89 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 146
TABLE 90 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS, BY REGION, 2023-2030 (USD MILLION) 146
TABLE 91 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER KITS & REAGENTS,
BY COUNTRY, 2023-2030 (USD MILLION) 146
TABLE 92 EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION) 147
TABLE 93 EPIGENETICS MARKET FOR ENZYMES, BY REGION, 2023-2030 (USD MILLION) 147
TABLE 94 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 148
TABLE 95 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 148
TABLE 96 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 149
TABLE 97 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 149
TABLE 98 MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY REGION,
2023-2030 (USD MILLION) 149
TABLE 99 GCC COUNTRIES: EPIGENETICS MARKET FOR ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 150
TABLE 100 EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY REGION,
2023-2030 (USD MILLION) 151
TABLE 101 NORTH AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 151
TABLE 102 EUROPE: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION) 152
TABLE 103 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 152
TABLE 104 LATIN AMERICA: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 153
TABLE 105 MIDDLE EAST: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES, BY REGION, 2023-2030 (USD MILLION) 153
TABLE 106 GCC COUNTRIES: EPIGENETICS MARKET FOR DNA-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 153
TABLE 107 EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES, BY REGION,
2023-2030 (USD MILLION) 154
TABLE 108 NORTH AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 109 EUROPE: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 155
TABLE 110 ASIA PACIFIC: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 156
TABLE 111 LATIN AMERICA: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 156
TABLE 112 MIDDLE EAST: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES,
BY REGION, 2023-2030 (USD MILLION) 156
TABLE 113 GCC COUNTRIES: EPIGENETICS MARKET FOR PROTEIN-MODIFYING ENZYMES,
BY COUNTRY, 2023-2030 (USD MILLION) 157
TABLE 114 EPIGENETICS MARKET FOR OTHER ENZYMES, BY REGION,
2023-2030 (USD MILLION) 157
TABLE 115 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION) 158
TABLE 116 EUROPE: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 158
TABLE 117 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY,
2023-2030 (USD MILLION) 159
TABLE 118 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION) 159
TABLE 119 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER ENZYMES, BY REGION,
2023-2030 (USD MILLION) 159
TABLE 120 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER ENZYMES, BY COUNTRY, 2023-2030 (USD MILLION) 160
TABLE 121 EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION,
2023-2030 (USD MILLION) 161
TABLE 122 NORTH AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 161
TABLE 123 EUROPE: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 124 ASIA PACIFIC: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 162
TABLE 125 LATIN AMERICA: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 163
TABLE 126 MIDDLE EAST: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES,
BY REGION, 2023-2030 (USD MILLION) 163
TABLE 127 GCC COUNTRIES: EPIGENETICS MARKET FOR INSTRUMENTS & ACCESSORIES,
BY COUNTRY, 2023-2030 (USD MILLION) 163
TABLE 128 EPIGENETICS MARKET FOR SOFTWARE, BY REGION, 2023-2030 (USD MILLION) 164
TABLE 129 NORTH AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY,
2023-2030 (USD MILLION) 165
TABLE 130 EUROPE: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY,
2023-2030 (USD MILLION) 165
TABLE 131 ASIA PACIFIC: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY,
2023-2030 (USD MILLION) 166
TABLE 132 LATIN AMERICA: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY,
2023-2030 (USD MILLION) 166
TABLE 133 MIDDLE EAST: EPIGENETICS MARKET FOR SOFTWARE, BY REGION,
2023-2030 (USD MILLION) 166
TABLE 134 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR SOFTWARE, BY COUNTRY, 2023-2030 (USD MILLION) 167
TABLE 135 EPIGENETICS MARKET FOR SERVICES, BY REGION, 2023-2030 (USD MILLION) 168
TABLE 136 NORTH AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY,
2023-2030 (USD MILLION) 168
TABLE 137 EUROPE: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY,
2023-2030 (USD MILLION) 169
TABLE 138 ASIA PACIFIC: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY,
2023-2030 (USD MILLION) 169
TABLE 139 LATIN AMERICA: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY,
2023-2030 (USD MILLION) 170
TABLE 140 MIDDLE EAST: EPIGENETICS MARKET FOR SERVICES, BY REGION,
2023-2030 (USD MILLION) 170
TABLE 141 GCC COUNTRIES: EPIGENETICS MARKET FOR SERVICES, BY COUNTRY,
2023-2030 (USD MILLION) 170
TABLE 142 EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 172
TABLE 143 EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION,
2023-2030 (USD MILLION) 174
TABLE 144 NORTH AMERICA: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY COUNTRY, 2023-2030 (USD MILLION) 174
TABLE 145 EUROPE: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 146 ASIA PACIFIC: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY COUNTRY, 2023-2030 (USD MILLION) 175
TABLE 147 LATIN AMERICA: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 148 MIDDLE EAST: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY REGION, 2023-2030 (USD MILLION) 176
TABLE 149 GCC COUNTRIES: EPIGENETICS MARKET FOR NEXT-GENERATION SEQUENCING,
BY COUNTRY, 2023-2030 (USD MILLION) 176
TABLE 150 EPIGENETICS MARKET FOR PCR & QPCR, BY REGION, 2023-2030 (USD MILLION) 178
TABLE 151 NORTH AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY,
2023-2030 (USD MILLION) 178
TABLE 152 EUROPE: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY,
2023-2030 (USD MILLION) 179
TABLE 153 ASIA PACIFIC: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY,
2023-2030 (USD MILLION) 179
TABLE 154 LATIN AMERICA: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY,
2023-2030 (USD MILLION) 180
TABLE 155 MIDDLE EAST: EPIGENETICS MARKET FOR PCR & QPCR, BY REGION,
2023-2030 (USD MILLION) 180
TABLE 156 GCC COUNTRIES: EPIGENETICS MARKET FOR PCR & QPCR, BY COUNTRY,
2023-2030 (USD MILLION) 180
TABLE 157 EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY REGION,
2023-2030 (USD MILLION) 182
TABLE 158 NORTH AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 182
TABLE 159 EUROPE: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY,
2023-2030 (USD MILLION) 183
TABLE 160 ASIA PACIFIC: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION) 183
TABLE 161 LATIN AMERICA: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2023-2030 (USD MILLION) 184
TABLE 162 MIDDLE EAST: EPIGENETICS MARKET FOR MASS SPECTROMETRY, BY REGION, 2023-2030 (USD MILLION) 184
TABLE 163 GCC COUNTRIES: EPIGENETICS MARKET FOR MASS SPECTROMETRY,
BY COUNTRY, 2023-2030 (USD MILLION) 184
TABLE 164 EPIGENETICS MARKET FOR SONICATION, BY REGION, 2023-2030 (USD MILLION) 185
TABLE 165 NORTH AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY,
2023-2030 (USD MILLION) 186
TABLE 166 EUROPE: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY,
2023-2030 (USD MILLION) 186
TABLE 167 ASIA PACIFIC: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY,
2023-2030 (USD MILLION) 187
TABLE 168 LATIN AMERICA: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY,
2023-2030 (USD MILLION) 187
TABLE 169 MIDDLE EAST: EPIGENETICS MARKET FOR SONICATION, BY REGION,
2023-2030 (USD MILLION) 187
TABLE 170 GCC COUNTRIES: EPIGENETICS MARKET FOR SONICATION, BY COUNTRY,
2023-2030 (USD MILLION) 188
TABLE 171 EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2023-2030 (USD MILLION) 189
TABLE 172 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023-2030 (USD MILLION) 189
TABLE 173 EUROPE: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,
2023-2030 (USD MILLION) 190
TABLE 174 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION) 190
TABLE 175 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 176 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION) 191
TABLE 177 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023-2030 (USD MILLION) 191
TABLE 178 EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 193
TABLE 179 EPIGENETICS MARKET FOR DNA METHYLATION, BY REGION,
2023-2030 (USD MILLION) 194
TABLE 180 NORTH AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION) 194
TABLE 181 EUROPE: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY,
2023-2030 (USD MILLION) 195
TABLE 182 ASIA PACIFIC: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION) 195
TABLE 183 LATIN AMERICA: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 184 MIDDLE EAST: EPIGENETICS MARKET FOR DNA METHYLATION, BY REGION,
2023-2030 (USD MILLION) 196
TABLE 185 GCC COUNTRIES: EPIGENETICS MARKET FOR DNA METHYLATION, BY COUNTRY, 2023-2030 (USD MILLION) 196
TABLE 186 COMMON HISTONE MODIFICATIONS AND RESPECTIVE LOCATIONS 197
TABLE 187 EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY REGION,
2023-2030 (USD MILLION) 198
TABLE 188 NORTH AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 198
TABLE 189 EUROPE: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 190 ASIA PACIFIC: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 199
TABLE 191 LATIN AMERICA: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 192 MIDDLE EAST: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS, BY REGION, 2023-2030 (USD MILLION) 200
TABLE 193 GCC COUNTRIES: EPIGENETICS MARKET FOR HISTONE MODIFICATIONS,
BY COUNTRY, 2023-2030 (USD MILLION) 200
TABLE 194 EPIGENETICS MARKET FOR OTHER METHODS, BY REGION,
2023-2030 (USD MILLION) 201
TABLE 195 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION) 201
TABLE 196 EUROPE: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY,
2023-2030 (USD MILLION) 202
TABLE 197 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY,
2023-2030 (USD MILLION) 202
TABLE 198 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 199 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER METHODS, BY REGION,
2023-2030 (USD MILLION) 203
TABLE 200 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER METHODS, BY COUNTRY, 2023-2030 (USD MILLION) 203
TABLE 201 EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 205
TABLE 202 EPIGENOME-TARGETING CANCER DRUGS APPROVED OR IN CLINICAL TRIALS 206
TABLE 203 EPIGENETICS MARKET FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION) 208
TABLE 204 NORTH AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 208
TABLE 205 EUROPE: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 209
TABLE 206 ASIA PACIFIC: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 209
TABLE 207 LATIN AMERICA: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 210
TABLE 208 MIDDLE EAST: EPIGENETICS MARKET FOR ONCOLOGY, BY REGION,
2023-2030 (USD MILLION) 210
TABLE 209 GCC COUNTRIES: EPIGENETICS MARKET FOR ONCOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 210
TABLE 210 EPIGENETICS MARKET FOR METABOLIC DISEASES, BY REGION,
2023-2030 (USD MILLION) 211
TABLE 211 NORTH AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 212
TABLE 212 EUROPE: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY,
2023-2030 (USD MILLION) 212
TABLE 213 ASIA PACIFIC: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 213
TABLE 214 LATIN AMERICA: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 213
TABLE 215 MIDDLE EAST: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY REGION, 2023-2030 (USD MILLION) 213
TABLE 216 GCC COUNTRIES: EPIGENETICS MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 214
TABLE 217 EPIGENETICS MARKET FOR IMMUNOLOGY, BY REGION,
2023-2030 (USD MILLION) 215
TABLE 218 NORTH AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 215
TABLE 219 EUROPE: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 216
TABLE 220 ASIA PACIFIC: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 216
TABLE 221 LATIN AMERICA: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 217
TABLE 222 MIDDLE EAST: EPIGENETICS MARKET FOR IMMUNOLOGY, BY REGION,
2023-2030 (USD MILLION) 217
TABLE 223 GCC COUNTRIES: EPIGENETICS MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023-2030 (USD MILLION) 217
TABLE 224 EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION,
2023-2030 (USD MILLION) 218
TABLE 225 NORTH AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 226 EUROPE: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION) 219
TABLE 227 ASIA PACIFIC: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 220
TABLE 228 LATIN AMERICA: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 220
TABLE 229 MIDDLE EAST: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023-2030 (USD MILLION) 220
TABLE 230 GCC COUNTRIES: EPIGENETICS MARKET FOR DEVELOPMENTAL BIOLOGY,
BY COUNTRY, 2023-2030 (USD MILLION) 221
TABLE 231 EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION,
2023-2030 (USD MILLION) 222
TABLE 232 NORTH AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023-2030 (USD MILLION) 222
TABLE 233 EUROPE: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023-2030 (USD MILLION) 223
TABLE 234 ASIA PACIFIC: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023-2030 (USD MILLION) 223
TABLE 235 LATIN AMERICA: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023-2030 (USD MILLION) 224
TABLE 236 MIDDLE EAST: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2023-2030 (USD MILLION) 224
TABLE 237 GCC COUNTRIES: EPIGENETICS MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023-2030 (USD MILLION) 224
TABLE 238 EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY REGION,
2023-2030 (USD MILLION) 225
TABLE 239 NORTH AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 226
TABLE 240 EUROPE: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2023-2030 (USD MILLION) 226
TABLE 241 ASIA PACIFIC: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 227
TABLE 242 LATIN AMERICA: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 227
TABLE 243 MIDDLE EAST: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION) 227
TABLE 244 GCC COUNTRIES: EPIGENETICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 228
TABLE 245 EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION) 230
TABLE 246 EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023-2030 (USD MILLION) 231
TABLE 247 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 231
TABLE 248 EUROPE: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 232
TABLE 249 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 232
TABLE 250 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 233
TABLE 251 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 233
TABLE 252 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 233
TABLE 253 EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION) 235
TABLE 254 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 235
TABLE 255 EUROPE: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 236
TABLE 256 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 236
TABLE 257 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 237
TABLE 258 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION) 237
TABLE 259 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 237
TABLE 260 EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS, BY REGION,
2023-2030 (USD MILLION) 239
TABLE 261 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 239
TABLE 262 EUROPE: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 240
TABLE 263 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 240
TABLE 264 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 241
TABLE 265 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2023-2030 (USD MILLION) 241
TABLE 266 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 241
TABLE 267 EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2023-2030 (USD MILLION) 242
TABLE 268 NORTH AMERICA: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 243
TABLE 269 EUROPE: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 243
TABLE 270 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 244
TABLE 271 LATIN AMERICA: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 244
TABLE 272 MIDDLE EAST: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION) 244
TABLE 273 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION) 245
TABLE 274 EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 247
TABLE 275 EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION) 248
TABLE 276 NORTH AMERICA: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 248
TABLE 277 EUROPE: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 249
TABLE 278 ASIA PACIFIC: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 249
TABLE 279 LATIN AMERICA: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 250
TABLE 280 MIDDLE EAST: EPIGENETICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION) 250
TABLE 281 GCC COUNTRIES: EPIGENETICS SERVICE MARKET PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION) 250
TABLE 282 EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023-2030 (USD MILLION) 251
TABLE 283 NORTH AMERICA: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 252
TABLE 284 EUROPE: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 252
TABLE 285 ASIA PACIFIC: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 253
TABLE 286 LATIN AMERICA: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 253
TABLE 287 MIDDLE EAST: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 253
TABLE 288 GCC COUNTRIES: EPIGENETICS SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION) 254
TABLE 289 EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION,
2023-2030 (USD MILLION) 255
TABLE 290 NORTH AMERICA: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 255
TABLE 291 EUROPE: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 256
TABLE 292 ASIA PACIFIC: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 256
TABLE 293 LATIN AMERICA: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 257
TABLE 294 MIDDLE EAST: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS,
BY REGION, 2023-2030 (USD MILLION) 257
TABLE 295 GCC COUNTRIES: EPIGENETICS SERVICE MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2023-2030 (USD MILLION) 257
TABLE 296 EPIGENETICS MARKET, BY REGION, 2023-2030 (USD MILLION) 259
TABLE 297 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 260
TABLE 298 NORTH AMERICA: EPIGENETICS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 261
TABLE 299 NORTH AMERICA: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 262
TABLE 300 NORTH AMERICA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 262
TABLE 301 NORTH AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 263
TABLE 302 NORTH AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 263
TABLE 303 NORTH AMERICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 264
TABLE 304 NORTH AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 264
TABLE 305 NORTH AMERICA: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 265
TABLE 306 NORTH AMERICA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 265
TABLE 307 NORTH AMERICA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 266

TABLE 308 US: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 267
TABLE 309 US: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION) 267
TABLE 310 US: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 268
TABLE 311 US: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION) 268
TABLE 312 US: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 269
TABLE 313 US: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 269
TABLE 314 US: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 269
TABLE 315 US: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION) 270
TABLE 316 US: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 270
TABLE 317 CANADA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 271
TABLE 318 CANADA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 271
TABLE 319 CANADA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 272
TABLE 320 CANADA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 272
TABLE 321 CANADA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 273
TABLE 322 CANADA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 273
TABLE 323 CANADA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 274
TABLE 324 CANADA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 274
TABLE 325 CANADA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 275
TABLE 326 EUROPE: KEY MACROECONOMIC INDICATORS 276
TABLE 327 EUROPE: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 277
TABLE 328 EUROPE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 277
TABLE 329 EUROPE: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 277
TABLE 330 EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 278
TABLE 331 EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 278
TABLE 332 EUROPE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 279
TABLE 333 EUROPE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 279
TABLE 334 EUROPE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 280
TABLE 335 EUROPE: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 280
TABLE 336 EUROPE: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 281
TABLE 337 GERMANY: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 281
TABLE 338 GERMANY: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 282
TABLE 339 GERMANY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 282
TABLE 340 GERMANY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 283
TABLE 341 GERMANY: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 283
TABLE 342 GERMANY: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 283
TABLE 343 GERMANY: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 284
TABLE 344 GERMANY: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 284
TABLE 345 GERMANY: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 285
TABLE 346 UK: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 286
TABLE 347 UK: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION) 286
TABLE 348 UK: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 287
TABLE 349 UK: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION) 287
TABLE 350 UK: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 288
TABLE 351 UK: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 288
TABLE 352 UK: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 289
TABLE 353 UK: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION) 289
TABLE 354 UK: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 290
TABLE 355 FRANCE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 291
TABLE 356 FRANCE: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 291
TABLE 357 FRANCE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 292
TABLE 358 FRANCE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 292
TABLE 359 FRANCE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 293
TABLE 360 FRANCE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 293
TABLE 361 FRANCE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 294
TABLE 362 FRANCE: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 294
TABLE 363 FRANCE: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 295
TABLE 364 ITALY: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 296
TABLE 365 ITALY: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 296
TABLE 366 ITALY: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 297
TABLE 367 ITALY: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION) 297
TABLE 368 ITALY: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 298
TABLE 369 ITALY: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 298
TABLE 370 ITALY: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 299
TABLE 371 ITALY: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 299
TABLE 372 ITALY: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 300
TABLE 373 SPAIN: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 300
TABLE 374 SPAIN: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 301
TABLE 375 SPAIN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 301
TABLE 376 SPAIN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 302
TABLE 377 SPAIN: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 302
TABLE 378 SPAIN: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 302
TABLE 379 SPAIN: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 303
TABLE 380 SPAIN: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 303
TABLE 381 SPAIN: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 304
TABLE 382 REST OF EUROPE: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 304
TABLE 383 REST OF EUROPE: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 305
TABLE 384 REST OF EUROPE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 305
TABLE 385 REST OF EUROPE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 306
TABLE 386 REST OF EUROPE: EPIGENETICS MARKET, BY METHOD,
2023-2030 (USD MILLION) 306
TABLE 387 REST OF EUROPE: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 306
TABLE 388 REST OF EUROPE: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 307
TABLE 389 REST OF EUROPE: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 307
TABLE 390 REST OF EUROPE: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 308
TABLE 391 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 309
TABLE 392 ASIA PACIFIC: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 311
TABLE 393 ASIA PACIFIC: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 311
TABLE 394 ASIA PACIFIC: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 312
TABLE 395 ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 312
TABLE 396 ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 313
TABLE 397 ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 313
TABLE 398 ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 313
TABLE 399 ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 314
TABLE 400 ASIA PACIFIC: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 314
TABLE 401 ASIA PACIFIC: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 315
TABLE 402 CHINA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 316
TABLE 403 CHINA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 316
TABLE 404 CHINA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 317
TABLE 405 CHINA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 317
TABLE 406 CHINA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 318
TABLE 407 CHINA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 318
TABLE 408 CHINA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 319
TABLE 409 CHINA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 319
TABLE 410 CHINA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 320
TABLE 411 JAPAN: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 321
TABLE 412 JAPAN: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 321
TABLE 413 JAPAN: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 322
TABLE 414 JAPAN: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 322
TABLE 415 JAPAN: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 323
TABLE 416 JAPAN: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 323
TABLE 417 JAPAN: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 324
TABLE 418 JAPAN: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 324
TABLE 419 JAPAN: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 325
TABLE 420 INDIA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 326
TABLE 421 INDIA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 326
TABLE 422 INDIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 327
TABLE 423 INDIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION) 327
TABLE 424 INDIA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 328
TABLE 425 INDIA: EPIGENETICS MARKET, BY TECHNOLOGY 2023-2030 (USD MILLION) 328
TABLE 426 INDIA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 329
TABLE 427 INDIA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 329
TABLE 428 INDIA: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 330
TABLE 429 AUSTRALIA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 330
TABLE 430 AUSTRALIA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 331
TABLE 431 AUSTRALIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 331
TABLE 432 AUSTRALIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 332
TABLE 433 AUSTRALIA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 332
TABLE 434 AUSTRALIA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 332
TABLE 435 AUSTRALIA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 333
TABLE 436 AUSTRALIA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 333
TABLE 437 AUSTRALIA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 334
TABLE 438 SOUTH KOREA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 334
TABLE 439 SOUTH KOREA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 335
TABLE 440 SOUTH KOREA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 335
TABLE 441 SOUTH KOREA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 336
TABLE 442 SOUTH KOREA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 336
TABLE 443 SOUTH KOREA: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 336
TABLE 444 SOUTH KOREA: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 337
TABLE 445 SOUTH KOREA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 337
TABLE 446 SOUTH KOREA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 338
TABLE 447 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 338
TABLE 448 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 339
TABLE 449 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION) 339
TABLE 450 REST OF ASIA PACIFIC: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 340
TABLE 451 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY METHOD,
2023-2030 (USD MILLION) 340
TABLE 452 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 340
TABLE 453 REST OF ASIA PACIFIC: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 341
TABLE 454 REST OF ASIA PACIFIC: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 341
TABLE 455 REST OF ASIA PACIFIC: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 342
TABLE 456 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 343
TABLE 457 LATIN AMERICA: EPIGENETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 343
TABLE 458 LATIN AMERICA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 343
TABLE 459 LATIN AMERICA: EPIGENETICS MARKET, BY TYPE, 2023-2030 (USD MILLION) 344
TABLE 460 LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 344
TABLE 461 LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 345
TABLE 462 LATIN AMERICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 345
TABLE 463 LATIN AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 345
TABLE 464 LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 346
TABLE 465 LATIN AMERICA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 346
TABLE 466 LATIN AMERICA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 347
TABLE 467 BRAZIL: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 347
TABLE 468 BRAZIL: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 348
TABLE 469 BRAZIL: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 348
TABLE 470 BRAZIL: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 349
TABLE 471 BRAZIL: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 349
TABLE 472 BRAZIL: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 349
TABLE 473 BRAZIL: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 350
TABLE 474 BRAZIL: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 350
TABLE 475 BRAZIL: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 351
TABLE 476 MEXICO: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 351
TABLE 477 MEXICO: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 352
TABLE 478 MEXICO: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 352
TABLE 479 MEXICO: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 353
TABLE 480 MEXICO: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 353
TABLE 481 MEXICO: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 353
TABLE 482 MEXICO: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 354
TABLE 483 MEXICO: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 354
TABLE 484 MEXICO: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 355
TABLE 485 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 355
TABLE 486 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 356
TABLE 487 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION) 356
TABLE 488 REST OF LATIN AMERICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 357
TABLE 489 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY METHOD,
2023-2030 (USD MILLION) 357
TABLE 490 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 357
TABLE 491 REST OF LATIN AMERICA: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 358
TABLE 492 REST OF LATIN AMERICA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 358
TABLE 493 REST OF LATIN AMERICA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 359
TABLE 494 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 360
TABLE 495 MIDDLE EAST: EPIGENETICS MARKET, BY REGION, 2023-2030 (USD MILLION) 360
TABLE 496 MIDDLE EAST: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 361
TABLE 497 MIDDLE EAST: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 361
TABLE 498 MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 362
TABLE 499 MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 362
TABLE 500 MIDDLE EAST: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 363
TABLE 501 MIDDLE EAST: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 363
TABLE 502 MIDDLE EAST: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 364
TABLE 503 MIDDLE EAST: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 364
TABLE 504 MIDDLE EAST: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 365
TABLE 505 GCC COUNTRIES: EPIGENETICS MARKET, BY COUNTRY,
2023-2030 (USD MILLION) 365
TABLE 506 GCC COUNTRIES: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 366
TABLE 507 GCC COUNTRIES: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 366
TABLE 508 GCC COUNTRIES: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 367
TABLE 509 GCC COUNTRIES: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 367
TABLE 510 GCC COUNTRIES: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 368
TABLE 511 GCC COUNTRIES: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 368
TABLE 512 GCC COUNTRIES: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 369
TABLE 513 GCC COUNTRIES: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 369
TABLE 514 GCC COUNTRIES: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 370
TABLE 515 SAUDI ARABIA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 371
TABLE 516 SAUDI ARABIA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 371
TABLE 517 SAUDI ARABIA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 372
TABLE 518 SAUDI ARABIA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 372
TABLE 519 SAUDI ARABIA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 373
TABLE 520 SAUDI ARABIA: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 373
TABLE 521 SAUDI ARABIA: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 374
TABLE 522 SAUDI ARABIA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 374
TABLE 523 SAUDI ARABIA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 375
TABLE 524 UAE: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 375
TABLE 525 UAE: EPIGENETICS MARKET FOR OFFERING, BY TYPE, 2023-2030 (USD MILLION) 376
TABLE 526 UAE: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 376
TABLE 527 UAE: EPIGENETICS MARKET FOR ENZYMES, BY TYPE, 2023-2030 (USD MILLION) 377
TABLE 528 UAE: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 377
TABLE 529 UAE: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 377
TABLE 530 UAE: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 378
TABLE 531 UAE: EPIGENETICS PRODUCT MARKET, BY END USER, 2023-2030 (USD MILLION) 378
TABLE 532 UAE: EPIGENETICS SERVICE MARKET, BY END USER, 2023-2030 (USD MILLION) 379
TABLE 533 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 379
TABLE 534 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 380
TABLE 535 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION) 380
TABLE 536 REST OF GCC COUNTRIES: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 381
TABLE 537 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY METHOD,
2023-2030 (USD MILLION) 381
TABLE 538 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 381
TABLE 539 REST OF GCC COUNTRIES: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 382
TABLE 540 REST OF GCC COUNTRIES: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 382
TABLE 541 REST OF GCC COUNTRIES: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 383
TABLE 542 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY OFFERING,
2023-2030 (USD MILLION) 383
TABLE 543 REST OF MIDDLE EAST: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 384
TABLE 544 REST OF MIDDLE EAST: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE, 2023-2030 (USD MILLION) 384
TABLE 545 REST OF MIDDLE EAST: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 385
TABLE 546 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY METHOD,
2023-2030 (USD MILLION) 385
TABLE 547 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY TECHNOLOGY,
2023-2030 (USD MILLION) 385
TABLE 548 REST OF MIDDLE EAST: EPIGENETICS MARKET, BY APPLICATION,
2023-2030 (USD MILLION) 386
TABLE 549 REST OF MIDDLE EAST: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 386
TABLE 550 REST OF MIDDLE EAST: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 387
TABLE 551 AFRICA: KEY MACROECONOMIC INDICATORS 388
TABLE 552 AFRICA: EPIGENETICS MARKET, BY OFFERING, 2023-2030 (USD MILLION) 388
TABLE 553 AFRICA: EPIGENETICS MARKET FOR OFFERING, BY TYPE,
2023-2030 (USD MILLION) 389
TABLE 554 AFRICA: EPIGENETICS MARKET FOR KITS & REAGENTS, BY TYPE,
2023-2030 (USD MILLION) 389
TABLE 555 AFRICA: EPIGENETICS MARKET FOR ENZYMES, BY TYPE,
2023-2030 (USD MILLION) 390
TABLE 556 AFRICA: EPIGENETICS MARKET, BY METHOD, 2023-2030 (USD MILLION) 390
TABLE 557 AFRICA: EPIGENETICS MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION) 390
TABLE 558 AFRICA: EPIGENETICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION) 391
TABLE 559 AFRICA: EPIGENETICS PRODUCT MARKET, BY END USER,
2023-2030 (USD MILLION) 391
TABLE 560 AFRICA: EPIGENETICS SERVICE MARKET, BY END USER,
2023-2030 (USD MILLION) 392
TABLE 561 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EPIGENETICS MARKET, JANUARY 2022-JULY 2025 393
TABLE 562 EPIGENETICS MARKET: DEGREE OF COMPETITION 396
TABLE 563 EPIGENETICS MARKET: REGION FOOTPRINT 403
TABLE 564 EPIGENETICS MARKET: OFFERING FOOTPRINT 403
TABLE 565 EPIGENETICS MARKET: METHOD FOOTPRINT 404
TABLE 566 EPIGENETICS MARKET: TECHNOLOGY FOOTPRINT 405
TABLE 567 EPIGENETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 408
TABLE 568 EPIGENETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 409
TABLE 569 EPIGENETICS MARKET: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025 410
TABLE 570 EPIGENETICS MARKET: DEALS, JANUARY 2022-JULY 2025 411
TABLE 571 EPIGENETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025 412
TABLE 572 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 413
TABLE 573 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 414
TABLE 574 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,
JANUARY 2022-JULY 2025 416
TABLE 575 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-JULY 2025 417
TABLE 576 ILLUMINA, INC.: COMPANY OVERVIEW 418
TABLE 577 ILLUMINA, INC.: PRODUCTS OFFERED 419
TABLE 578 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025 421
TABLE 579 ILLUMINA, INC.: DEALS, JANUARY 2022-JULY 2025 421
TABLE 580 MERCK KGAA: COMPANY OVERVIEW 423
TABLE 581 MERCK KGAA: PRODUCTS OFFERED 424
TABLE 582 PACBIO: COMPANY OVERVIEW 427
TABLE 583 PACBIO: PRODUCTS OFFERED 428
TABLE 584 PACBIO: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025 429
TABLE 585 PACBIO: DEALS, JANUARY 2022-JULY 2025 430
TABLE 586 PACBIO: EXPANSIONS, JANUARY 2022- JULY 2025 430
TABLE 587 DANAHER: COMPANY OVERVIEW 432
TABLE 588 DANAHER: PRODUCTS OFFERED 433
TABLE 589 DANAHER: DEALS, JANUARY 2022-JULY 2025 435
TABLE 590 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 436
TABLE 591 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 437
TABLE 592 ACTIVE MOTIF: COMPANY OVERVIEW 441
TABLE 593 ACTIVE MOTIF: PRODUCTS OFFERED 441
TABLE 594 ACTIVE MOTIF: DEALS, JANUARY 2022-JULY 2025 444
TABLE 595 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 445
TABLE 596 NEW ENGLAND BIOLABS: PRODUCTS OFFERED 445
TABLE 597 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025 447
TABLE 598 NEW ENGLAND BIOLABS: DEALS, JANUARY 2022-JULY 2025 448
TABLE 599 QIAGEN: COMPANY OVERVIEW 449
TABLE 600 QIAGEN: PRODUCTS OFFERED 450
TABLE 601 QIAGEN: PRODUCT LAUNCHES, JANUARY 2022-JULY 2025 451
TABLE 602 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW 452
TABLE 603 ZYMO RESEARCH CORPORATION: PRODUCTS OFFERED 452
TABLE 604 ZYMO RESEARCH CORPORATION: PRODUCT LAUNCHES,
JANUARY 2022-JULY 2025 455
TABLE 605 ZYMO RESEARCH CORPORATION: EXPANSIONS, JANUARY 2022-JULY 2025 455
TABLE 606 ZYMO RESEARCH CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022-JULY 2025 455
TABLE 607 REVVITY: COMPANY OVERVIEW 456
TABLE 608 REVVITY: PRODUCTS OFFERED 457
TABLE 609 REVVITY: DEALS, JANUARY 2022-JULY 2025 458
TABLE 610 HOLOGIC, INC. COMPANY OVERVIEW 459
TABLE 611 HOLOGIC, INC.: PRODUCTS OFFERED 460
TABLE 612 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 463
TABLE 613 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 464
TABLE 614 PROMEGA CORPORATION: COMPANY OVERVIEW 466
TABLE 615 PROMEGA CORPORATION: PRODUCTS OFFERED 466
TABLE 616 EPIGENTEK GROUP INC.: COMPANY OVERVIEW 468
TABLE 617 EPIGENTEK GROUP INC.: PRODUCTS OFFERED 468
TABLE 618 EPICYPHER: COMPANY OVERVIEW 472
TABLE 619 FIOS GENOMICS: COMPANY OVERVIEW 473
TABLE 620 GENOMESCAN: COMPANY OVERVIEW 474
TABLE 621 CREATIVE BIOGENE: COMPANY OVERVIEW 475
TABLE 622 BPS BIOSCIENCE, INC.: COMPANY OVERVIEW 475
TABLE 623 ABNOVA CORPORATION: COMPANY OVERVIEW 477
TABLE 624 CREATIVE DIAGNOSTICS: COMPANY OVERVIEW 478
TABLE 625 BIOMODAL: COMPANY OVERVIEW 479
TABLE 626 INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW 480
TABLE 627 NOVOGENE CO., LTD.: COMPANY OVERVIEW 481